期刊文献+

邯郸市2008-2011年疑似预防接种异常反应报告情况分析 被引量:3

Analysis on reporting situation of adverse events following immunization in Handan from 2008 to 2011
原文传递
导出
摘要 目的了解邯郸市2008-2011年疑似预防接种异常反应(adverse events following immunization,AEFI)报告情况,为更好地提高预防接种服务质量提供依据。方法将2008-2011年邯郸市AEFI监测数据导入Excel表后进行整理分析。结果 AEFI病例报告有地区差异性,全年各月均有报告,主要在5~8月。8 165例AEFI中≤1岁年龄组报告例数最多,共6 963例(85.28%),其中3~6月龄报告例数最多(77.16%);报告病例中接种后24h发生反应的4377例(53.61%);AEFI病例以一般反应为主,共7 615例(93.26%),主要为发热/红肿/硬结7 559例(99.26%);报告病例中治愈6 955例(85.18%)、好转1 184例(14.5%)、出现后遗症和死亡15例(0.19%)、不详11例(0.13%)。结论开展预防接种后出现的AEFI回顾性调查,全面分析发生的原因,对今后避免和处理类似事件有重要意义。 Objective To know about the reporting situation of adverse events following immunization (AEFI) in Handan from 2008 to 2011, so as to provide basis for improving the quality of vaccination services. Methods The data of AEFI in Handan during 2008 -2011 was input into Excel andthen analyzed. Results The AEFI cases had regional differences, and they occurred in each month, mostly happened from May to August. 85.28% of the AEFI cases were smaller than 1 -year -old which mostly was from 3 to 6 months (77. 16% ) There were 4 377 cases reported after inoculation in 24h (53.61%) . The AEFI cases were mainly general reactions (93.26%), which mostly were fever, swelling or callosity (99. 26% ) . The number of AEFI cases who were cured, improved, appeared sequelae and died and not quite clear were 6 955 (85.18%), 1 184 (14.5%), 15 (0.09%) andll (0.1%) respectively. Conclusions The retrospective investigation of AEFI cases was carried out, and the reasons were analyzed entirely which will be significant to avoid and deal with the similar events.
出处 《医学动物防制》 2013年第8期847-849,共3页 Journal of Medical Pest Control
关键词 疑似预防接种异常反应 疫苗 发生率 Adverse events following immunization Vaccine Incidence rate
  • 相关文献

参考文献3

二级参考文献10

  • 1郭飚.全球预防接种副反应监测系统的建立与发展[J].中国计划免疫,2005,11(3):229-233. 被引量:63
  • 2张苏琳,王越,孙骏,徐厚明.中美预防接种不良事件监测系统比较[J].药物流行病学杂志,2005,14(5):309-313. 被引量:16
  • 3李书华,陈国英,李琼,李斌,张发香,郑景山,蔡碧,严毅,王运超,周红俊,邓万霞,顾琼,黄璟,潘洁,刘爱东.湖北省2005年预防接种副反应监测分析[J].中国热带医学,2007,7(1):136-138. 被引量:8
  • 4WHO/WPRO. Immunization Safety Surveillance: Guidelines for Managers of Immunization Programmes on Reporting and Investigating Adverse Events Following Immunization [ M]. Manila: WHO/WPRO. 1999.5-7.
  • 5[1]卫生部.预防接种工作规范[S].2005.
  • 6[4]WHO & WPRO,Immunization Safety Surveillance:Guidelines for Managers of Immunization Programmes on Reporting and Investigating Adverse Events Following Immunization[M].Manila,Phillipines,1999.
  • 7[5]Matthew M,Nikki T.Suggestions for improving the monitoring of adverse events following immunization in New Zealand[J].New Engl J Med.2002,115:1162-1166.
  • 8郭飚,刘大卫,曹雷,曹玲生,庄菱,尚鹏辉,梁晓峰.中国2005年预防接种副反应试点监测数据分析[J].中国计划免疫,2007,13(4):353-358. 被引量:34
  • 9中国疾病预防控制中心.预防接种副反应监测试点工作指南[S].,2005..
  • 10卫生部.预防接种工作规范[S].2005.

共引文献74

同被引文献28

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部